Cindy Na-Young Kang,Monica Shah,Jerry Tan
Cindy Na-Young Kang
The diagnosis and classification of rosacea has been modified to reflect presenting features. On exclusion of differentials, the diagnosis of rosacea is based on the presence of either (1) phymatous changes, or (2) centrofacial persistent e...
Maria Leis,Patrick Fleming,Charles W Lynde
Maria Leis
Prurigo nodularis (PN) is a chronic, recalcitrant inflammatory skin condition characterized by the presence of pruritic nodules. The exact pathogenesis of the disease is unknown, although immune and neural dysregulation are indicated in dri...
Review
Skin therapy letter. 2021 May;26(3):5-8. DOI: 2021
Ryan D Gotesman,Ron Vender
Ryan D Gotesman
Psoriasis is an immune-mediated inflammatory skin disease that affects about 2% of the population and is associated with many comorbidities. Recent advances have demonstrated interleukin (IL)-17 signaling plays a crucial role in the pathoge...
Utility of the Human Papillomavirus Vaccination in Management of HPV-associated Cutaneous Lesions [0.03%]
人乳头瘤病毒疫苗在HPV相关皮肤病变管理中的作用
Jane Gay,Nathan Johnson,Varun Kavuru et al.
Jane Gay et al.
Human papillomavirus (HPV)-induced cutaneous disease is a common complaint for patients presenting for dermatology evaluation. Infection by HPV is the major etiologic factor in the development of cutaneous warts, epidermodysplasia verrucifo...
Review
Skin therapy letter. 2021 Mar;26(2):6-8. DOI: 2021
Jeremy Strain,Maria Leis,Kyle O Lee et al.
Jeremy Strain et al.
Psoriasis is a chronic, immune-mediated skin condition which commonly affects women of childbearing age. Certolizumab pegol (CZP) is an anti-tumor necrosis factor-alpha (anti-TNFα) agent that has demonstrated long-term safety and efficacy ...
Review
Skin therapy letter. 2021 Mar;26(2):1-5. DOI: 2021
Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis [0.03%]
10％特比萘芬溶液（乔利巴）每天一次治疗趾甲癣性甲真菌病的长期疗效和安全性：一项中期分析
Aditya K Gupta,Elizabeth A Cooper
Aditya K Gupta
Onychomycosis, a difficult-to-treat fungal nail infection, is more prevalent in the elderly. Efinaconazole 10% topical solution is a firstline therapy for onychomycosis, based on phase III trials of 12-month treatment; the slow growth of on...
Clinical Trial
Skin therapy letter. 2021 Jan;26(1):5-10. DOI: 2021
Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis [0.03%]
crisaborole克里萨伯 ole2%软膏治疗中度至轻度特应性皮炎效果好
Aryan Riahi,Joseph M Lam
Aryan Riahi
Atopic dermatitis (AD) is a chronic, relapsing, inflammatory condition marked by pruritus and traditionally treated with topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI). Crisaborole 2% ointment (a topical phosphodiest...
Reed Huber,Aaron Wong
Reed Huber
Nicotinamide (or niacinamide), a form of vitamin B3 that is often confused with its precursor nicotinic acid (or niacin), is a low-cost, evidence-based oral treatment option for actinic keratosis, squamous cell carcinomas, basal cell carcin...
Nicole W Kittler,Kelly M Cordoro
Nicole W Kittler
While the association between psoriasis and various comorbidities is well documented in adults, questions remain as to whether the same relationships exist in the pediatric population. However, psoriasis develops in childhood or adolescence...
Case Reports
Skin therapy letter. 2020 Nov;25(5):1-6. DOI: 2020
Dermatologic Applications and Safety Considerations of Janus Kinase Inhibitors [0.03%]
Janus激酶抑制剂的皮肤应用及安全性考虑
Steven A Svoboda,Nathan Johnson,Mariana Phillips
Steven A Svoboda
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, represent a new class of medication that have broad potential to treat dermatologic disease. Currently, the only FDA-approved dermatologic indication for this class of medic...
Review
Skin therapy letter. 2020 Sep;25(4):6-11. DOI: 2020